Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future

Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future

Bibliographic Details
Main Authors:	Fan Jin, Huan-ling Wang
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220301478

Similar Items

Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future …
by: Guillaume Desoubeaux, et al.
Published: (2020-06-01)

Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future…
by: Guillaume Desoubeaux, et al.
Published: (2020-06-01)

Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia
by: Wen-Sen Lee
Published: (2017-08-01)

Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review
by: Gül Ruhsar YILMAZ, et al.
Published: (2024-03-01)

Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia
by: Robin Koshy, et al.
Published: (2019-01-01)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
by: Janson C, et al.
Published: (2017-10-01)

Efficacy of caspofungin combined with clindamycin for Pneumocystis jirovecii pneumonia in a systemic lupus erythematosus patient: A case report and literature review
by: Di-hong Yang, et al.
Published: (2019-01-01)

Pneumocystis pneumonia
by: Atousa HAKAMIFARD, et al.
Published: (2019-12-01)

Pneumocystis Pneumonia
by: Jang-Jih Lu, et al.
Published: (2008-11-01)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia*
by: Huang L.
Published: (2011-02-01)

Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics
by: C Sanz-Rodriguez, et al.
Published: (2005-11-01)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
by: Roya Sattarzadeh Badkoubeh, et al.
Published: (2022-08-01)

Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale
by: Janssen R, et al.
Published: (2019-11-01)

Current Epidemiology of Pneumocystis Pneumonia
by: Alison Morris, et al.
Published: (2004-10-01)

Pneumocystis carinii Pneumonia (PCP)
by: Praijitr Tanan
Published: (2015-02-01)

Endocarditis, Meningitis and Pneumocystis Pneumonia
by: Filipa Silva, et al.
Published: (2017-04-01)

Peran Steroid pada Pneumocystis Pneumonia Ditinjau Berdasarkan Imunopatogenesis [Immunopathogenesis of Steroid in Pneumocystis Pneumonia]
by: Resti Yudhawati, et al.
Published: (2019-05-01)

Lifethreatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia
by: N du Plooy, et al.
Published: (2019-02-01)

Pneumocystis jirovecii pneumonia in developing countries*
by: De Armas Rodríguez Y., et al.
Published: (2011-08-01)

Pneumocystis pneumonia mimicking COVID-19
by: Alexander V. Averyanov, et al.
Published: (2020-08-01)

Lymphocyte apoptosis in murine <it>Pneumocystis </it>pneumonia
by: Ruan Sanbao, et al.
Published: (2009-06-01)

Pneumocystis pneumonia in patients with Hodgkin lymphoma
by: T N Moiseeva, et al.
Published: (2014-11-01)

Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
by: Irina Ullmann, et al.
Published: (2022-06-01)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
by: Whitney Rabacal, et al.
Published: (2022-12-01)

Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
by: Andrea Duminuco, et al.
Published: (2021-11-01)

Pneumocystis carinii pneumonia with pleurisy, platypnoea and orthodeoxia.
by: Newton, P, et al.
Published: (2003)

Pneumocystis pneumonia in patients with acquired immunodeficiency syndrome
by: Falah Abass Mohamed Salih
Published: (2016)

Pneumocystis jirovecii pneumonia: a case report
by: Jacqueline Gri, et al.
Published: (2024-02-01)

Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia
by: Michael J. Linke, et al.
Published: (2003-12-01)

Pneumocystis jirovecii pneumonia following corticosteroid therapy
by: Magda Garça, et al.
Published: (2023-02-01)

Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia
by: Sadatomo Tasaka, M.D.
Published: (2020-04-01)

A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital
by: Hao Li, et al.
Published: (2024-01-01)

Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
by: Eka Prasetya Budi Mulia, et al.
Published: (2021-09-01)

Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with pneumocystis pneumonia
by: Fan Jin, et al.
Published: (2021-05-01)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
by: Alastair David Bezzina, et al.
Published: (2022-01-01)

A Case of Severe Pneumocystis Pneumonia in an HIV-Negative Patient Successfully Treated with Oral Atovaquone
by: Hirai J, et al.
Published: (2023-03-01)

Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries
by: Fyezah Jehan, et al.
Published: (2019-08-01)

<i>Pneumocystis</i> Pneumonia: Immunity, Vaccines, and Treatments
by: Aaron D. Gingerich, et al.
Published: (2021-02-01)

The Pathogenesis and Diagnosis of <i>Pneumocystis jiroveci</i> Pneumonia
by: Anna Apostolopoulou, et al.
Published: (2022-11-01)

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
by: Albert Dunbar, et al.
Published: (2020-05-01)